Internal Medicine, Rheumatology · Indianapolis, IN
NPI
1922192301
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1110 W Michigan St, Room #545
Indianapolis, IN, 46202
Phone (317) 274-7724
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
234 services
Medicare patients, 2024
93
Average age 65
Drug cost, 2024
$1.3M
915 prescriptions
Company payments, 2023
$14.37
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Renee C Moenning was code 99214 (office e&m - established), 104 times for 57 patients. In total Renee C Moenning billed 234 services in 9 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 104 | 57 | $65.44 | $6,806 |
| 99214 Office E&M - Established | Office | 38 | 20 | $88.57 | $3,366 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 35 | 29 | $12.23 | $428 |
| 99204 Office E&M - New | Facility | 19 | 19 | $98.08 | $1,864 |
| 99213 Office E&M - Established | Facility | 14 | 12 | $47.59 | $666 |
By year: 2022 $14K for 220 services; 2023 $14K for 213 services; 2024 $15K for 234 services.
Medicare prescription drug claims, 2024
In 2024, the drug Renee C Moenning prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 179 prescriptions and refills. In total Renee C Moenning wrote 915 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 179 | 390 | 47 | $7,190 |
| Methotrexate Methotrexate Sodium | 121 | 230 | 28 | $2,451 |
| Prednisone Generic | 106 | 247 | 42 | $697 |
| Colchicine Generic | 49 | 62 | Under 11 | $1,769 |
| Sulfasalazine Generic | 36 | 71 | Under 11 | $804 |
| Pilocarpine Hcl Generic | 35 | 53 | Under 11 | $2,843 |
| Humira Adalimumab | 31 | 31 | Under 11 | $455K |
| Orencia Clickject Abatacept | 28 | 28 | Under 11 | $155K |
| Allopurinol Generic | 25 | 73 | Under 11 | $163 |
| Folic Acid Generic | 23 | 59 | Under 11 | $230 |
| Azathioprine Generic | 22 | 27 | Under 11 | $431 |
| Enbrel Sureclick Etanercept | 21 | 21 | Under 11 | $166K |
| Mitigare Colchicine | 20 | 32 | Under 11 | $4,685 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 18 | 22 | Under 11 | $145 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 17 | 17 | Under 11 | $208 |
Brand drugs: - claims; generic drugs: 693 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Renee C Moenning $14.37 ($14.37 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $14.37.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $14.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.